ELOCTATE 1000

Țară: Israel

Limbă: engleză

Sursă: Ministry of Health

Ingredient activ:

COAGULATION FACTOR VIII

Disponibil de la:

SANOFI - AVENTIS ISRAEL LTD

Codul ATC:

B02BD05

Forma farmaceutică:

POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Compoziție:

COAGULATION FACTOR VIII 1000 IU

Calea de administrare:

I.V

Tip de prescriptie medicala:

Required

Produs de:

BIOGEN IDEC LIMITED , UK

Zonă Terapeutică:

COAGULATION FACTOR VII

Indicații terapeutice:

ELOCTATE [Antihemophilic Factor (Recombinant Fc Fusion Protein)] is a long-acting antihemophilic factor (recombinant) indicated in adults and children12 years of age and older with Hemophilia A (congenital factor VIII deficiency) for:• Control and prevention of bleeding episodes.• Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.• Perioperative management (surgical prophylaxis).ELOCTATE is not indicated for the treatment of von Willebrand disease.

Data de autorizare:

2017-01-09